# Respiratory Agents - Monoclonal Antibodies-Anti-IL/Anti-IgE 

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EfWn6aIsBylHsa3otKiVyncBMXnf26t5IO2jopTMi1OI-A?e=zeyWfC){:target="_blank" rel="noopener}

|||
| ---------- | -------------------------------------------- |
| Criteria 1 | Preferred Agents – Fasenra (PA), Xolair (PA) |
| Criteria 2 | Preferred Agents – Dupixent (PA)             |
| Criteria 3 | Non-Preferred Agents – Nucala, Tezspire      |
  

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Respiratory Agents: Monoclonal Antibodies-Anti-IL/Anti-IgE</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Fasenra, Xolair</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code(s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>FASENRA</td>
<td>077921</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>FASENRA</td>
<td>080268</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XOLAIR</td>
<td>052758</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>XOLAIR</td>
<td>067907</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>XOLAIR</td>
<td>067908</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1  </td>
<td>0998</td>
<td>  </td>
<td> Select   </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </p>
<p>    </p></td>
<td>New Start (initial authorization request)</td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1234  </td>
</tr>
<tr class="odd">
<td>2  </td>
<td>0999 </td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3  </td>
<td>1000 </td>
<td>  </td>
<td>Select  </td>
<td>Is the medication being prescribed by or in consultation with an applicable specialist (i.e., allergist/immunologist, pulmonologist, or otolaryngologist)? </td>
<td>Y  </td>
<td>1001 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4 </td>
<td>1001 </td>
<td>  </td>
<td>Select  </td>
<td><p>What is the patient’s diagnosis? </p>
<p> </p></td>
<td>Asthma </td>
<td>2000 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Rhinosinusitis with Nasal Polyposis </td>
<td>3000 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Urticaria </td>
<td>4000 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>5 </td>
<td>2000 </td>
<td> </td>
<td>Select </td>
<td><p>What is the patient’s age?  </p>
<p> </p></td>
<td>6-11 years old </td>
<td>2001 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>12 years and older </td>
<td>2002 </td>
</tr>
<tr class="odd">
<td>6 </td>
<td>2001 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler? </p>
<p>If yes, please submit the medication trials and dates.  </p></td>
<td>Y  </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>7 </td>
<td>2002 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler with tiotropium or high dose ICS/LABA inhaler?  </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td><p>Y </p>
<p> </p></td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>8 </td>
<td>3000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> to at least <span class="underline">one oral</span> corticosteroid AND <span class="underline">one nasal</span> corticosteroid spray?</p>
<p> </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>9 </td>
<td>4000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response to at least <span class="underline">14 days</span> with at least <span class="underline">two different</span> antihistamines? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td><p>Y  </p>
<p> </p></td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1233</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?</p>
<p>If yes, please submit the medication name and reason for inability to use. </p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>11</td>
<td>1234</td>
<td> </td>
<td>Select and Free Text </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring (i.e., Pulmonary Function Test (PFT) improvement, reduced affected Body Surface Area (BSA))?</td>
<td>Y  </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>12</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>13</td>
<td>1236</td>
<td></td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: Initial: 180 days; Subsequent: 365 days 

| **Last Approved ** | 4/13/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Immunomodulator Agents: Systemic Inflammatory Disease and Respiratory Agents: Monoclonal Antibodies-Anti-IL/Anti-IgE</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Dupixent</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>DUPIXENT</td>
<td>077263</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DUPIXENT</td>
<td>079179</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DUPIXENT</td>
<td>081231</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>DUPIXENT</td>
<td>081615</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>DUPIXENT</td>
<td>082769</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>   </th>
<th><strong>Question ID</strong>   </th>
<th><strong>Default Next Question ID</strong>   </th>
<th><strong>Question Type</strong>   </th>
<th><strong>Question Text</strong>   </th>
<th><strong>Choice Text</strong>   </th>
<th><strong>Next Question ID</strong>   </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1   </td>
<td>0999</td>
<td></td>
<td>Select</td>
<td>What is the patient’s diagnosis?</td>
<td>Asthma  </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Rhinosinusitis with Nasal Polyposis  </td>
<td>2000</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Urticaria  </td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Alopecia Areata</td>
<td>1235</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Atopic dermatitis  </td>
<td>3000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Plaque psoriasis  </td>
<td>1235</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Ulcerative colitis  </td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>2</td>
<td>1000</td>
<td></td>
<td>Select    </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?     </p>
<p>     </p></td>
<td>New Start (initial authorization request)</td>
<td>1001  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1001</td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y</td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>4</td>
<td>1002</td>
<td></td>
<td>Select</td>
<td>Is the medication being prescribed by or in consultation with an applicable specialist (i.e., allergist/ immunologist, pulmonologist, or otolaryngologist)? </td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>5</td>
<td>1003</td>
<td></td>
<td>Select   </td>
<td><p>What is the patient’s age?  </p>
<p>  </p></td>
<td>6-11 years old  </td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>12 years and older  </td>
<td>1005</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1004</td>
<td></td>
<td>Select and Free Text  </td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler?  </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1006</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler with tiotropium or high dose ICS/LABA inhaler?  </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y   </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>1006</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1006</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)? </p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>9</td>
<td>2000</td>
<td></td>
<td>Select    </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?     </p>
<p>     </p></td>
<td>New Start (initial authorization request)  </td>
<td>2001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1233</td>
</tr>
<tr class="odd">
<td>10</td>
<td>2001</td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? </td>
<td>Y</td>
<td>2002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>11</td>
<td>2002</td>
<td></td>
<td>Select</td>
<td>Is the medication being prescribed by or in consultation with an applicable specialist (i.e., allergist/ immunologist, pulmonologist, or otolaryngologist)?</td>
<td>Y</td>
<td>2003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>12</td>
<td>2003</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> to at least <span class="underline">one oral</span> corticosteroid AND <span class="underline">one nasal</span> corticosteroid spray?  </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y   </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N   </td>
<td>2004</td>
</tr>
<tr class="odd">
<td>13</td>
<td>2004</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)? </p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>14</td>
<td>3000  </td>
<td></td>
<td>Select   </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </p>
<p>    </p></td>
<td>New Start (initial authorization request)</td>
<td>3001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>15</td>
<td>3001</td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling? </td>
<td>Y</td>
<td>3002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>16</td>
<td>3002</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Authorization of dosing regimens (loading/maintenance) will be based upon diagnosis.  </p>
<p> </p>
<p>Has the provider submitted documentation of the requested loading and maintenance dosing, if applicable?</p></td>
<td>Y</td>
<td>3003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>17</td>
<td>3003</td>
<td></td>
<td>Select</td>
<td>Does the patient have a current, active infection? </td>
<td>Y</td>
<td>1235</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>3004</td>
</tr>
<tr class="odd">
<td>18</td>
<td>3004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted evidence of a negative tuberculosis (TB) test prior to initiation of biologic therapy, if required by labeling?</td>
<td>Y</td>
<td>3005</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>19</td>
<td>3005</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">two applicable</span> first-line drugs indicated for diagnosis?</p>
<p>If yes, please provide documentation of the trialed drugs, dosages, dates, and durations.</p></td>
<td>Y</td>
<td>3007</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>3006</td>
</tr>
<tr class="odd">
<td>20</td>
<td>3006</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)? </p>
<p>If yes, please submit the medication name and reason for inability to use.</p></td>
<td>Y    </td>
<td>3007</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N    </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>21</td>
<td>3007</td>
<td></td>
<td>Select and Free Text</td>
<td><p>Does the patient have at least 10% body surface area (BSA) involvement with two of the following: topical corticosteroids or topical calcineurin inhibitors [e.g., Elidel]?</p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y    </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N    </td>
<td>3008</td>
</tr>
<tr class="odd">
<td>22</td>
<td>3008</td>
<td></td>
<td>Select</td>
<td>Is the patient’s atopic dermatitis severe and involves greater than 25% BSA?</td>
<td>Y </td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1236  </td>
</tr>
<tr class="odd">
<td>23</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring (i.e., Pulmonary Function Test (PFT) improvement, reduced affected Body Surface Area (BSA))? </td>
<td> Y    </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>24</td>
<td>1234</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring?</td>
<td> Y    </td>
<td>END (Pending Manual Review)  </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td> N    </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>25</td>
<td>1235  </td>
<td>  </td>
<td>Free Text  </td>
<td>Please provide the rationale for the medication being requested.   </td>
<td>END (Pending Manual Review)  </td>
<td></td>
</tr>
<tr class="even">
<td>26</td>
<td>1236  </td>
<td>  </td>
<td>Free Text </td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)  </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS:

Respiratory Agents: Monoclonal Antibodies-Anti-IL/Anti-IgE - Initial:
180 days; Subsequent: 365 days 

Immunomodulator Agents: Systemic Inflammatory Disease- Initial: 90 days;
Subsequent: 365 days 

| **Last Approved ** | 4/13/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Respiratory Agents: Monoclonal Antibodies-Anti-IL/Anti-IgE</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Nucala, Tezspire</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>NUCALA</td>
<td>075111</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NUCALA</td>
<td>079828</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>NUCALA</td>
<td>079829</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>NUCALA</td>
<td>083454</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>TEZSPIRE</td>
<td>082944</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1  </td>
<td>0998</td>
<td>  </td>
<td>Select   </td>
<td><p>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </p>
<p>    </p></td>
<td>New Start (initial authorization request)</td>
<td>0999</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1234</td>
</tr>
<tr class="odd">
<td>2  </td>
<td>0999</td>
<td></td>
<td>Select  </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1000 </td>
<td>  </td>
<td>Select  </td>
<td>Is the medication being prescribed by or in consultation with an applicable specialist (i.e., allergist/immunologist, pulmonologist, or otolaryngologist)? </td>
<td>Y  </td>
<td>1001 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1001 </td>
<td>  </td>
<td>Select  </td>
<td><p>What is the patient’s diagnosis? </p>
<p> </p></td>
<td>Asthma </td>
<td>2000 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Rhinosinusitis with Nasal Polyposis </td>
<td>3000 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chronic Urticaria </td>
<td>4000 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>5</td>
<td>2000 </td>
<td> </td>
<td>Select  </td>
<td><p>What is the patient’s age? </p>
<p> </p></td>
<td>6-11 years old </td>
<td>2001 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>12 years and older </td>
<td>2002 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>2001 </td>
<td> </td>
<td>Select and Free Text   </td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y </td>
<td>1230</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>7</td>
<td>2002 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had uncontrolled asthma symptoms and/or exacerbations despite at least <span class="underline">30 days</span> with a medium dose preferred ICS/LABA inhaler with tiotropium or high dose ICS/LABA inhaler? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>1230</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>8</td>
<td>3000 </td>
<td> </td>
<td>Select and Free Text  </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">30 days</span> to at least <span class="underline">one oral</span> corticosteroid AND <span class="underline">one nasal</span> corticosteroid spray? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y  </td>
<td>1230 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>9</td>
<td>4000 </td>
<td> </td>
<td>Select and Free Text</td>
<td><p>Has the patient had an inadequate clinical response to at least <span class="underline">14 days</span> with at least <span class="underline">two different</span> antihistamines? </p>
<p> </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td><p>Y  </p>
<p> </p></td>
<td>1230</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1236</td>
</tr>
<tr class="odd">
<td>10</td>
<td>1230</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">90 days</span> with at least <span class="underline">one preferred</span> drug? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>1232</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1231</td>
</tr>
<tr class="odd">
<td>11 </td>
<td>1231</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?  </p>
<p> </p>
<p>If yes, please submit the medication name and reason for inability to use.   </p></td>
<td>Y</td>
<td>1232</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>12</td>
<td>1232</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1233</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="odd">
<td>13</td>
<td>1233</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>END (Pending Manual Review)</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>14</td>
<td>1234</td>
<td> </td>
<td>Select and Free Text </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring (i.e., Pulmonary Function Test (PFT) improvement, reduced affected Body Surface Area (BSA))?</td>
<td>Y  </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>15</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
<tr class="even">
<td>16</td>
<td>1236 </td>
<td> </td>
<td>Free Text</td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.</td>
<td>END (Pending Manual Review)</td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: Initial: 180 days; Subsequent: 365 days 

| **Last Approved ** | 4/13/2023 |
| ------------------ | --------- |
| **Other**          |           |
